174 related articles for article (PubMed ID: 36147914)
1. Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease.
Sargur Madabushi S; Fouda R; Ghimire H; Abdelhamid AMH; Lim JE; Vishwasrao P; Kiven S; Brooks J; Zuro D; Rosenthal J; Guha C; Gupta K; Hui SK
Front Oncol; 2022; 12():969429. PubMed ID: 36147914
[TBL] [Abstract][Full Text] [Related]
2. Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice.
Lim JE; Sargur Madabushi S; Vishwasrao P; Song JY; Abdelhamid AMH; Ghimire H; Vanishree VL; Lamba JK; Dandapani S; Salhotra A; Lemecha M; Pierini A; Zhao D; Storme G; Holtan S; Aristei C; Schaue D; Al Malki M; Hui SK
Front Oncol; 2022; 12():1045016. PubMed ID: 36439420
[TBL] [Abstract][Full Text] [Related]
3. First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies.
Zuro D; Madabushi SS; Brooks J; Chen BT; Goud J; Salhotra A; Song JY; Parra LE; Pierini A; Sanchez JF; Stein A; Malki MA; Kortylewski M; Wong JYC; Alaei P; Froelich J; Storme G; Hui SK
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):671-683. PubMed ID: 34119592
[TBL] [Abstract][Full Text] [Related]
4. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation.
Wong JY; Liu A; Schultheiss T; Popplewell L; Stein A; Rosenthal J; Essensten M; Forman S; Somlo G
Biol Blood Marrow Transplant; 2006 Mar; 12(3):306-15. PubMed ID: 16503500
[TBL] [Abstract][Full Text] [Related]
5. Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review.
Wong JYC; Liu A; Han C; Dandapani S; Schultheiss T; Palmer J; Yang D; Somlo G; Salhotra A; Hui S; Al Malki MM; Rosenthal J; Stein A
Front Oncol; 2022; 12():1003908. PubMed ID: 36263219
[TBL] [Abstract][Full Text] [Related]
6. Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents.
Hui S; Takahashi Y; Holtan SG; Azimi R; Seelig D; Yagi M; Ingvalson J; Alaei P; Sharkey L; Kodal B; Peterson N; Meyer C; Godin L; Ehrhardt M; Storme G; Zhou D; Panoskaltsis-Mortari A
Radiother Oncol; 2017 Sep; 124(3):468-474. PubMed ID: 28778346
[TBL] [Abstract][Full Text] [Related]
7. Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up.
Ladbury C; Armenian S; Bosworth A; He T; Wong FL; Dandapani S; Han C; Liu A; Al Malki M; Rosenthal J; Stein A; Wong J
Transplant Cell Ther; 2022 Dec; 28(12):860.e1-860.e6. PubMed ID: 36167306
[TBL] [Abstract][Full Text] [Related]
8. Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation.
Haraldsson A; Wichert S; Engström PE; Lenhoff S; Turkiewicz D; Warsi S; Engelholm S; Bäck S; Engellau J
Eur J Haematol; 2021 Oct; 107(4):393-407. PubMed ID: 34107104
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
[TBL] [Abstract][Full Text] [Related]
10. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
11. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.
Corvò R; Zeverino M; Vagge S; Agostinelli S; Barra S; Taccini G; Van Lint MT; Frassoni F; Bacigalupo A
Radiother Oncol; 2011 Mar; 98(3):382-6. PubMed ID: 21339008
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens.
Shinde A; Yang D; Frankel P; Liu A; Han C; Del Vecchio B; Schultheiss T; Cheng J; Li R; Kim D; Radany EH; Hui S; Somlo G; Rosenthal J; Stein A; Forman S; Wong JYC
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1025-1033. PubMed ID: 31421151
[TBL] [Abstract][Full Text] [Related]
13. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Hui S; Brunstein C; Takahashi Y; DeFor T; Holtan SG; Bachanova V; Wilke C; Zuro D; Ustun C; Weisdorf D; Dusenbery K; Verneris MR
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1110-1116. PubMed ID: 28396164
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation.
Wong JY; Forman S; Somlo G; Rosenthal J; Liu A; Schultheiss T; Radany E; Palmer J; Stein A
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):148-56. PubMed ID: 22592050
[TBL] [Abstract][Full Text] [Related]
15. Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments.
Han C; Liu A; Wong JYC
Pract Radiat Oncol; 2020; 10(5):e406-e414. PubMed ID: 32302694
[TBL] [Abstract][Full Text] [Related]
16. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
[TBL] [Abstract][Full Text] [Related]
17. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
Kean LS; Durham MM; Adams AB; Hsu LL; Perry JR; Dillehay D; Pearson TC; Waller EK; Larsen CP; Archer DR
Blood; 2002 Mar; 99(5):1840-9. PubMed ID: 11861303
[TBL] [Abstract][Full Text] [Related]
18. Growth factor treatment prior to low-dose total body irradiation increases donor cell engraftment after bone marrow transplantation in mice.
Noach EJ; Ausema A; Dillingh JH; Dontje B; Weersing E; Akkerman I; Vellenga E; de Haan G
Blood; 2002 Jul; 100(1):312-7. PubMed ID: 12070042
[TBL] [Abstract][Full Text] [Related]
19. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
Krishnamurti L; Kharbanda S; Biernacki MA; Zhang W; Baker KS; Wagner JE; Wu CJ
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1270-8. PubMed ID: 18940682
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
Ruffner KL; Martin PJ; Hussell S; Nourigat C; Fisher DR; Bernstein ID; Matthews DC
Cancer Res; 2001 Jul; 61(13):5126-31. PubMed ID: 11431350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
